# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055651
Filing Date
2024-05-08
Accepted
2024-05-08 16:10:52
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bdsx-20240331.htm iXBRL | 10-Q | 1637819
2 | EX-31.1 | bdsx-ex31_1.htm | EX-31.1 | 14123
3 | EX-31.2 | bdsx-ex31_2.htm | EX-31.2 | 14141
4 | EX-32.1 | bdsx-ex32_1.htm | EX-32.1 | 7378
5 | EX-32.2 | bdsx-ex32_2.htm | EX-32.2 | 7603
| Complete submission text file | 0000950170-24-055651.txt |  | 8915079

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bdsx-20240331.xsd | EX-101.SCH | 1821097
77 | EXTRACTED XBRL INSTANCE DOCUMENT | bdsx-20240331_htm.xml | XML | 1319086

Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 24926123
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)